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Introduction
Inflammation of the marginal periodontium
(Parodontitis marginalis), caused by plaque
accumulation on the tooth surface and in the
adjacent soft tissue, leads to a gradual loss of
periodontal tissue (alveolar bone, root cement and
desmodontal fiber apparatus) in case of insufficient
oral hygiene. As a physiological counter-reaction
on the inflammatory processes, the proliferation of
affected tissue cells is initiated. Along with an apical
migration and lateral extension, the cells of the
gingival junctional epithelium proliferate more
quickly than the cells of the lower-level desmodontal
fiber apparatus. As a consequence, deep gingival
pockets and bone pockets develop, that prevent a
physiological regeneration of the tooth supporting
apparatus. In the long run, this will mean for the
patient that the teeth in the jaw areas that are
affected by the inflammation will loosen or even
get lost. In progressive periodontal therapy the
strategy is to inhibit the deep growth of the epithelium
mechanically on the basis of Guided Tissue
Regeneration by artificial barriers. This way
periodontal regeneration shall be improved 1,2.
However, from the histological and clinical
perspectives, this therapy alone could achieve only
partly satisfying results with clearly restricted
indication 3,4,5.The option of affecting the growth
processes of cells and tissues by applying specific
substances provides an alternative to the
mechanical therapy 6. The principles of a future
innovative approach to the therapy of parodontal
diseases which are presented here, describe the
growth retardation of the gingival epithelium by using
antibodies against certain cellular adhesion
molecules (CAM) on the surface of these cells.
This method generates a barrier on molecular level,
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Summary
 Successful guided tissue regeneration (GTR) should result in a functional attachment apparatus
of the periodontium. The crucial points in the healing process are potential microbiological
colonization of mechanical barrier membranes, lacking contact to the connective tissue and apical
growth of the gingival epithelium. The membranes‘ success might be improved by equipping them
with antibiotics, specific inhibitors for the epithelial growth and growth factors for periodontal
ligament cells (PLC) or progenitor cells. Monoclonal antibodies (mAb) directed to integrin subunits
α6 and β1 were tested for their specificity to epithelial growth. In vitro assays were performed as
direct and indirect contact by seeding the human HaCaT-cell-line and gingival fibroblasts.
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which is to enable the cells of the periodontal
ligament to regenerate physiologically 7.
Precondition for the postperiodontal re-
epithelisation is the closed contact between cells of
the gingival junctional epithelium and their
extracellular matrix (ECM). It is provided by
interactions between specific receptors on the
surface of the epithelium cells – the so called
integrins and adhesive components of extracellular
matrices such as collagen, laminin or fibronectin.
The integrins have extracellularly oriented epitopes
that consist of α- and β-subunits. Their specificity
for different ligands – such as the mentioned ECMs,
immunoglobins or the Willebrand-factor - results
from the different combinations of subunits 8-15. If
the cell-matrix-interactions between the integrins
and the ECM are interrupted, the migration of the
gingival epithelium should be prevented. Actually,
the first studies of our laboratory carried out with
organ cultures of marginal gingival biopsies could
show that a blockage of the integrin-subunits α6
and β1 through monoclonal antibodies (mAb) leads
to a significant inhibition of the epithelium’s growth
16,17
. However, the proven inhibition of expression
and growth of the human gingival epithelium through
anti-α6-, and anti-β1-antibodies was not quantified
in the past examinations. Furthermore, in the organ
assay it remained unclear whether the applied
antibodies will suppress both the migration and the
proliferation of epithelium cells. In the present study,
these parameters have, therefore, been inspected
at a human permanent keratinocyte cell line HaCaT
(German Cancer Research Center (DKFZ),
Heidelberg), that exprimate the integrin subunits α6
and β1, too. Compared to the gingival epithelium,
HaCaT-cells are of homologous histogenetic origin.
In addition to this, they show in-vitro growth
characteristics, which are close to those of the
native epithelium cells 18. Another important aspect
for assessing the possible clinical use of the tested
antibodies is their effect to the cells of the periodontal
ligament. If the growth of even these cells was
inhibited, this would counteract against the
postperiodontal physiological regeneration of the
periodontium, so this would cause a contra-
productive undesired effect. Therefore, the effect
of the used antibodies especially on the proliferation
behavior of this cell type should be examined. A
primary fibroblasts‘ culture from human gingiva was
selected as model. Fibroblasts are the main
population in the desmodontal cells and are evenly
distributed in the desmodont because of their function
– producing the collagen fiber apparatus. So, they
Materials and methods
HaCaT-cell line: The HaCaT cell line is a human,
spontaneously transformed permanent keratinocyte
cell line 19. HaCaT-cells are routinely cultivated in
DMEM, adding penicillin (400 U/ml), streptomycin
(50 µg/ml) and 10 % fetal calf serum at 37°C and
7,5 % CO2.
Fibroblasts-primary culture: Biopsies of human
gingiva are cultivated in 6-corrugated boards at 37°C
and 7,5 % CO2 in DMEM, adding penicillin (400 U/
ml), streptomycin (50 µg/ml) and 10 % fetal calf
serum for 14 days. Both after 7 and 10 days, the
culture medium is exchanged. During the second
week, the fibroblasts grow out of the biopsies as
cellular lawn. After 14 days, the pieces are remo-
ved from the culture, the fibroblasts are taken off
by using Trypsin/EDTA and sawed in cell culture
bottles for another cultivation 7. The fibroblasts of
the 3rd to 7th passage are used in proliferation-assays
Rat-Anti-Mouse-α6: CD49f (Immunotech,
Marseille, F); Mouse-Anti-Human- β1: P4C10
(Biomol, Hamburg, G); Anti-Rat-IgG FITC-
conjugated (Sigma, Deisenhofen, G); Anti-Mouse-
IgG Cy3-conjugated (Biomol, Hamburg, G).
Expression evidence of the integrin subunits α6
and β1: Anti-α6-FITC-marking 20. 500 µl of a cell
suspension (45.000 cells/ml) are given in each whole
of a 8-corrugated flexiperm board. 24 h later, the
cells are fixed with acetone/ethanol (1:1) at -20°C
for 10 minutes. After rinsing, blocking is effected
with 2 % BSA in PBS for 20 minutes. Incubation
with primary antibody (dilution: 1:40) at 37°C for
45 minutes. Afterwards, the cells are three times
washed with Tween 20 followed by incubation with
the secondary antibody (dilution: 1:128) at 37°C for
45 minutes. After this, the cells are washed again
three times with Tween 20 and incubated with 60
% glycerol in 0,1 M Tris-buffer, pH 9,3. Finally, the
cells are washed three times again and the
fluorescence is detected in the confocal laser-scan-
microscopy at 488 nm. Anti-β1-Cy3-conjugation 21.
500µl of a cell suspension (45.000 cells/ml) are given
into each whole of a 8-corrugated flexiperm board.
24 h later the medium is sucked off. The cells are
fixed with 70 % ethanol at room temperature for
15 minutes. After rinsing, incubation with 0,1 M
glycine in 0,05 M Tris-HCl (pH 7,4) for 20 minutes,
followed by blocking with 3 % BSA in PBS for 30
are a cell faction which is representative for the
intended studies.
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Results and discussion
To prove the integrin expression, the integrin
subunits α6 and β1 were detected both on the cell
line HaCaT and on the used primary culture of
human gingival fibroblasts through
immunohistochemical fluorescence marks. The
corresponding incubation with the primary
monoclonal antibodies anti-α6 and anti-β1
respectively was followed by another incubation
with the relevant secondary antibodies which are
linked with fluorescence. Both the FITC-conjugated
α6 and the Cy3-conjugated β1-subunits are
apparently distributed over the entire surface of the
cells. Control group cells which have been
incubated with the secondary antibodies only, were
not visibly colored in fluorescence-microscopic
reference. Contrary to the positive integrin evidence
on the permanent cell line HaCaT, the same
methods did not succeed in specifically proving the
expression of the integrin subunits α6 and β1 with
the used fibroblast primary culture from biopsies of
human gingiva.
By blocking the integrin subunits α6 and β1 with
monoclonal antibodies, the proliferation of the
HaCaT-cells which represent gingival epithelium,
should be suppressed. In this process, the inhibition
of the proliferation of the subepithelial periodontal
ligament was absolutely undesired for the purpose
of the intended complete postperiodontal
regeneration. To find out, whether the applied
antibodies really inhibited the proliferation of the
cells, it is necessary to catch the cells in an
exponential growth phase, i.e. during the S-phase
with active DNA-replication. Therefore, growth
charts where recorded from the cell cultures
Figure 1:  Growth charts of the permanent cell line HaCaT (left hand side), and of primary cultures of human gingival
fibroblasts (right hand side). Trypsinated cells from previous passages of the corresponding cultures were seeded
in a density of 17.000 c/cm2 (HaCaT) and 25000 c/cm2 (fibroblasts) on polystyrene boards and incubated at 37°C. In
intervals of 24 hours, the cell number was counted in the hemocytometer. Results arise from n=3 independent
experiments; data ± SEM.
minutes. Incubation with the primary antibody
(dilution 1:1500) at 37°C for 45 minutes. After
washing, incubation with the secondary antibody
(dilution: 1:40) at 37°C for 60 minutes. Finally the
cells are washed three times with PBS and detected
in the confocal laser-scan-microscopy at 565 nm.
Colorimetric cell proliferation test with Bromo-
2-deoxy-Uridine (BrdU-Labeling-Kitt, Boehringer,
Mannheim, D): The antibodies‘ effect on the
proliferation of the used HaCaT cell line is inspected
in the BrdU-test. A 96-multi corrugated board is
colonized with cells (30.000 cells/ml, 100 µl per
corrugation). After 24 and 48 hours, antibodies (anti-
α6: 5 µg/ml, anti-β1: 0,56 µg/ml) are added to the
cells. The antibodies are used both individually and
in combination. Control groups remain free of
antibodies. 72 hours later, the effect on cell
proliferation is inspected in the BrdU-test 22-26. In
another test series, antibodies are added to the
HaCaT-cells after 24, 48 and 72 hours. After 96
hours, the effect of the antibodies is checked once
again in the BrdU-test. In addition, the antibodies‘
effect also on the proliferation behavior of the
fibroblasts is inspected in the BrdU-test. Cells of a
subconfluent culture are taken off and suspended
to 3x104 cells/ml. 100 µl of the suspension are given
into each corrugation of a 96 multi corrugated board.
48 hours later, the antibodies are added to the cells
in the above given concentration. Negative tests
remain free of antibodies. The influence on
proliferation is measured after 72 hours in the BrdU-
test (BrdU-incorporation 3 h, substrate reaction 20
min.). For the positive test, cells in all test series
are incubated with 10 % ethanol in the medium.
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(HaCaT cell line and human fibroblast primary
culture) in their native status, before using them for
the proliferation test. After passaging the HaCaT-
cells the initial cell concentration is 17.000 c/cm2.
After a lag-phase of one day, the exponential growth
phase starts for a period of more than 72 hours
(Figure 1, left hand side). The initial cell
concentration of the gingival fibroblasts after seeding
is 25.000 c/cm2. Similar to the HaCaT-cells, the
logarithmic growth phase starts after 24 hours at
the latest and ends after about 48 hours (Figure 1,
right hand side). But even after 72 hours of
incubation, a subconfluent monolayer can still be
recognized in the microscopic picture, where the
majority of cells is not yet inhibited by contacts from
cell to cell.     The conditions for the proliferation
tests were derived on the basis of the growth
parameters which were found out. Two different
periods were selected for the antibody incubation
of the HaCaT cells - a) 48 hours and b) 72 hours.
For the control proof of the antibodies‘ effects on
the fibroblasts‘ culture, we limited the procedure to
72 hours of incubation. The influence of the used
mAbs on the mitotic activity of the cells was
ascertained in the BrdU-test. In a first dose-
response-screening with HaCaT-cells, antibody
concentrations of 5 µg/ml for anti-α6 and 0,56 µg/
ml for anti-β1 proved to be effective amounts. In
comparison to the untreated cells (negative con-
trol), the proliferation of the cells was inhibited
significantly by using both individually and commonly
applied antibodies (Figure. 2). Besides the used
concentration, the incubation time is decisive for
the extend of inhibition. Compared to the 48 hours
of incubation (Figure 2, top) the proliferation rates
of the cells with 72 hours of incubation were still
reduced by half (Figure 2, bottom). In contrary to
this, the antibodies did not show any inhibiting effect
on the proliferation of the fibroblasts‘ primary
culture, even after 72 hours of incubation. (Figure
3). Applying mAb against the integrin subunit α6
even resulted in a slight increase of the proliferation.
Integrins are cellular adhesion molecules, which
connect different structures of extracellular matri-
ces such as laminin, collagen or fibronectin. The
integrins‘ interactions serve to transmit signals and
Figure 2:  Effects of anti-α6- and anti-β1-antibodies on
the proliferation of the human permanent cell line HaCaT.
Log-phase-cells were incubated for 48 h (top) and 72 h
(bottom) with and without the mentioned mAbs or with
10 % (v/v) ethanol (positive control). Consequently, the
mitotic activities of the cells were ascertained by using
the BrdU-test in ELIZA at λ=450 nm. Statistical
evaluation: the data originate from n=48 independent
measurements; data ± SEM; (***): p<0,001 compared to
the negative control (ANOVA for paired samples).
Figure 3:  Effects of anti-α6- and anti-β1-antibodies on
the proliferation of human gingiva fibroblasts. Log-
phase-cells were incubated for 72 h with and without the
mentioned mAbs or with 10 % (v/v) ethanol (positive
control). Consequently, the mitotic activities of the cells
were ascertained by using the BrdU-test in ELIZA at
λ=450 nm. Statistical evaluation: the data originate from
n=48 independent measurements; data ± SEM; (***):
p<0,001 and (**): p<0,01 compared to the negative con-
trol (ANOVA for paired samples).
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control different processes in and on the cells, on
molecular level 27. In epithelial cells these are in
particular growth processes during the wound
healing periods 28-33. Earlier investigations could
show, that in humans integrins are exprimated in all
epithelial cells 34. In the gingival epithelium,
especially the integrin subunits α6 and β1 are co-
exprimated 35. So, this is the case on the human
keratinocyte line HaCaT, too. Growth inhibiting
effects of monoclonal antibodies against β1-integrin
subunits could be proved for the first time by Hergott
et. al., in 1993.
In the present study, we used monoclonal
antibodies against both integrin subunits, and
examined their specific effectiveness with reference
to the proliferation of epithelial keratinocytes. Both,
isolated application and combined application of
antibodies lead to a significant reduction of the cell
proliferation. For an intended clinical effect in the
treatment of periodontal diseases, it will be of par-
ticular importance that the mAb do not have any
inhibitory effects on the proliferation of the
remaining gingival tissue. In our tests, it was not
observed that the proliferation of human gingiva
fibroblasts was inhibited by either of the used
antibodies, anti-α6 and anti-β1. So, the undesired
deep growth of the gingival junctional epithelium
can be suppressed in a controlled and directed way
on the molecular level. At the same time this allows
to provide the deeper fiber generating cells of the
connective tissue with the possibility to refill the
periodontal defect completely. The in vivo
effectiveness on the postperiodontal regeneration
will be inspected in a planned animal experiment in
the dog model by releasing mAbs against the integrin
subunits α6 and β1 in a drug release system.
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